Drug intelligence / Profile preview

potassium aspartate (Köhler Pharma)

Development stage
Unknown
Lead developer
Köhler-Pharma
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Potassium hydrogen DL-aspartate is a small molecule electrolyte replenisher consisting of the potassium salt of racemic DL-aspartic acid. It is primarily indicated for the treatment of potassium deficiency (hypokalemia) and associated cardiovascular conditions, particularly cardiac arrhythmias and heart rate disorders. The aspartate moiety is thought to act as an effective carrier that facilitates the transport of potassium ions into the intracellular space, which is critical for maintaining the resting membrane potential of cardiomyocytes and supporting myocardial function. In clinical practice, it is frequently formulated in combination with magnesium aspartate to address combined electrolyte deficiencies, as magnesium is a necessary cofactor for the sodium-potassium ATPase pump. Experimental studies have also suggested that it may provide protective effects against oxidative stress-induced cell damage and has been explored for applications in liver conditions such as hepatitis and general liver dysfunction.

Brand names
Trophicard-KöhlerAspacardinAsparomKfleboPotassio Aspartato
Other names
Potassium hydrogen DL-aspartatePotassium DL-aspartateMonopotassium aspartatePotassium hydrogen aspartatePotassium aspartate

Beyond the preview

Go deeper on potassium aspartate (Köhler Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium aspartate (Köhler Pharma).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call